Long non-coding RNA HOTAIR is a marker for hepatocellular carcinoma progression and tumor recurrence

Oncology Letters

Volumn 11, Issue 3, 2016, Pages 1791-1798

  Gao, Jian Zhi ^a,b   Li, Jia ^b,c   Du, Jing Li ^b   Li, Xiao Lei ^b  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; HOX transcript antisense RNA; Long non coding RNA; Progression; Recurrence

Indexed keywords

ALPHA FETOPROTEIN; BETA ACTIN; BETA CATENIN; COMPLEMENTARY RNA; HOX TRANSCRIPT ANTISENSE RNA; LONG UNTRANSLATED RNA; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FILTERS AND MEMBRANES; GENETIC ASSOCIATION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LENTIVIRUS INFECTION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; MRNA EXPRESSION ASSAY; MTT ASSAY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR RECURRENCE; TUMOR XENOGRAFT; WNT SIGNALING PATHWAY;

EID: 84958093285     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.4130     Document Type: Article

References (41)

1. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
2. Bosch FX, Ribes J, Diaz M and Cléries R: Primary liver cancer: Worldwide incidence and trends. Gastroenterology 127 (5 Suppl 1): S5-S16, 2004.
3. Turdean S, Gurzu S, Turcu M, Voidazan S and Sin A: Current data in clinicopathological characteristics of primary hepatic tumors. Rom J Morphol Embryol 53 (Suppl 3): 719-724, 2012.
4. Severi T, van Malenstein H, Verslype C and van Pelt JF: Tumor initiation and progression in hepatocellular carcinoma: Risk factors, classification and therapeutic targets. Acta pharmacol Sin 31: 1409-1420, 2010.
5. Tang ZY: Hepatocellular carcinoma surgery-review of the past and prospects for the 21st century. J Surg Oncol 91: 95-96, 2005.
6. Qi LN, Bai T, Chen ZS, Wu FX, Chen YY, De Xiang B, Peng T, Han ZG and Li LQ: The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China: Role of chronic hepatitis B virus infection and aflatoxin B1 exposure. Liver Int 35: 999-1009, 2015.
7. Ye H, Zhang C, Wang BJ, Tan XH, Zhang WP, Teng Y and Yang X: Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice. Oncogene 33: 5133-5138, 2014.
8. Li J, Gao JZ, Du JL and Wei LX: Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 20: 6336-6344, 2014.
9. Sun Q, Wang R, Wang Y, et al: Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma. Oncol Rep 31: 933-939, 2014.
10. Zhang CH, Xu GL, Jia WD, Ge YS, Li JS, Ma JL and Ren WH: Prognostic significance of osteopontin in hepatocellular carcinoma: A meta-analysis. Int J Cancer 130: 2685-2692, 2012.
11. Xie L, Jiang H and Wu F: Role of Wnt/β-catenin signaling pathway in promoting tumorigenesis of hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 34: 913-917, 2014 (In Chinese).
12. Janku F, Kaseb AO, Tsimberidou AM, Wolff RA and Kurzrock R: Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. Oncotarget 5: 3012-3022, 2014.
13. Perkel JM: Visiting ‘noncodarnia’. Biotechniques 54: 301, 303-304, 2013.
14. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermüller J, Hofacker IL, et al: RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316: 1484-1488, 2007.
15. Hung T and Chang HY: Long noncoding RNA in genome regulation: Prospects and mechanisms. RNA Biol 7: 582-585, 2010.
16. Koerner MV, Pauler FM, Huang R and Barlow DP: The function of non-coding RNAs in genomic imprinting. Development 136: 1771-1783, 2009.
17. Costanzi C and Pehrson JR: Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature 393: 599-601, 1998.
18. Fu X, Ravindranath L, Tran N, Petrovics G and Srivastava S: Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol 25: 135-141, 2006.
19. Reis EM, Nakaya HI, Louro R, Canavez FC, Flatschart AV, Almeida GT, Egidio CM, Paquola AC, Machado AA, Festa F, et al: Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer. Oncogene 23: 6684-6692, 2004.
20. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and Chang HY: Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311-1323, 2007.
21. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076, 2010.
22. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693, 2010.
23. Wu ZH, Wang XL, Tang HM, Jiang T, Chen J, Lu S, Qiu GQ, Peng ZH and Yan DW: Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncol Rep 32: 395-402, 2014.
24. Huang J, Ke P, Guo L, Wang W, Tan H, Liang Y and Yao S: Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo. Int J Gynecol Cancer 24: 635-642, 2014.
25. Liu XH, Liu ZL, Sun M, Liu J, Wang ZX and De W: The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer 13: 464, 2013.
26. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, Kim S and Safe S: HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32: 1616-1625, 2013.
27. Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW, Jin HY, Zhang Y, Li Q and Hua KQ: Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol Oncol 134: 121-128, 2014.
28. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
29. Shao R, Bao S, Bai X, Blanchette C, Anderson RM, Dang T, Gishizky ML, Marks JR and Wang XF: Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 24: 3992-4003, 2004.
30. Edge SB and Compton CC: The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17: 1471-1474, 2010.
31. Farazi PA and DePinho RA: Hepatocellular carcinoma pathogenesis: From genes to environment. Nat Rev Cancer 6: 674-687, 2006.
32. Hu TH, Wang CC, Huang CC, Chen CL, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS and Tai MH: Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection. Oncol Rep 18: 1417-1426, 2007.
33. Niland CN, Merry CR and Khalil AM: Emerging roles for long non-coding RNAs in cancer and neurological disorders. Front Genet 3: 25, 2012.
34. Spizzo R, Almeida MI, Colombatti A and Calin GA: Long non-coding RNAs and cancer: A new frontier of translational research? Oncogene 31: 4577-4587, 2012.
35. Li X, Wu Z, Mei Q, Li X, Guo M, Fu X and Han W: Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma. Br J Cancer 109: 2266-2278, 2013.
36. Gupta RA, Shah N, Wang KC, et al: Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076, 2010.
37. Geng YJ, Xie SL, Li Q, Ma J and Wang GY: Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res 39: 2119-2128, 2011.
38. Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ, Huang L, Yu PF and Cheng XD: Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int J Biol Sci 9: 587-597, 2013.
39. Ge XS, Ma HJ, Zheng XH, Ruan HL, Liao XY, Xue WQ, Chen YB, Zhang Y and Jia WH: HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway. Cancer Sci 104: 1675-1682, 2013.
40. Qu B, Liu BR, Du YJ, Chen J, Cheng YQ, Xu W and Wang XH: Wnt/β-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma. Oncol Lett 7: 1175-1178, 2014.
41. Dahmani R, Just PA and Perret C: The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 35: 709-713, 2011.